lobbying_activities: 2311969

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2311969	6ac1a22d-eac9-4859-b163-89d2ad215a43	Q2	BROYDRICK & ASSOCIATES	7268	EXELA PHARMA SCIENCES	2019	second_quarter	PHA	Drug shortages and FDA approval. USTR acceptance.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2019-07-18T21:31:09.363000-04:00